Reports from Huazhong University of Science and Technology Add New Data to Research in Acute Myeloid Leukemia (A Prospective Clinical Study of Venetoclax Plus Azacitidine for the Maintenance Treatment of Post-Remission Acute Myeloid Leukemia).

Předmět:	ACUTE myeloid leukemia MYELOID leukemia MEDICAL research DRUG therapy STEM cell transplantation
Zdroj:	Hematology Week; 12/23/2024, p2227-2227, 1p
Abstrakt:	A report from Huazhong University of Science and Technology discusses research on acute myeloid leukemia, focusing on the use of azacitidine and venetoclax as maintenance therapy for patients in remission. The study aimed to evaluate the efficacy and safety of this treatment regimen in AML patients not immediately eligible for stem cell transplantation. Preliminary findings suggest that venetoclax combined with lower dose azacitidine is a feasible and safe maintenance strategy, with ongoing updates on the study results. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu